DSL(603233)2024-10-30 11:05Financial Performance - Total revenue for Q3 2024 reached ¥6,385,657,234.34, an increase of 11.42% compared to the same period last year[2] - Net profit attributable to shareholders was ¥200,529,111.41, a decrease of 21.95% year-on-year[2] - The net profit after deducting non-recurring gains and losses was ¥193,500,433.51, down 26.47% from the previous year[2] - Basic earnings per share decreased to ¥0.18, down 21.74% year-on-year[3] - The net profit for Q3 2024 was approximately ¥914.06 million, a decrease of 25.2% compared to ¥1.22 billion in Q3 2023[23] - The total profit for Q3 2024 was approximately ¥1.18 billion, down from ¥1.59 billion in Q3 2023, representing a decrease of 26.0%[23] - The operating profit for Q3 2024 was approximately ¥1.19 billion, down from ¥1.60 billion in Q3 2023, reflecting a decline of 26.0%[23] - Basic earnings per share for Q3 2024 were ¥0.75, down from ¥1.03 in Q3 2023, indicating a decrease of 27.2%[24] - The total comprehensive income for Q3 2024 was approximately ¥914.06 million, compared to ¥1.22 billion in Q3 2023, reflecting a decline of 25.2%[24] Cash Flow and Assets - Operating cash flow for the quarter was ¥742,160,000, a decline of 26.07% compared to the same period last year[3] - The company's cash and cash equivalents rose to CNY 5,708,268,822.26 from CNY 4,416,348,231.47, marking an increase of approximately 29.2%[18] - The cash flow from operating activities for the first three quarters of 2024 was ¥2.51 billion, slightly up from ¥2.48 billion in the same period of 2023[26] - The company reported a net cash outflow from investing activities of approximately ¥1.93 billion for Q3 2024, compared to a net outflow of ¥1.83 billion in Q3 2023[26] - The cash and cash equivalents at the end of Q3 2024 totaled approximately ¥3.15 billion, an increase from ¥3.01 billion at the end of Q3 2023[27] Assets and Liabilities - Total assets at the end of the reporting period were ¥25,879,469,178.00, an increase of 7.28% from the end of the previous year[3] - The company's total liabilities increased to CNY 17,754,335,270.38 from CNY 16,190,216,085.34, reflecting a rise of approximately 9.66%[20] - Inventory as of September 30, 2024, was CNY 4,206,599,416.89, slightly up from CNY 4,181,248,317.61 at the end of 2023, showing a marginal increase[19] - The total equity attributable to shareholders increased to CNY 6,870,201,366.68 from CNY 6,823,853,093.57, showing a growth of about 0.68%[21] Investments and Acquisitions - The company completed 13 mergers and acquisitions in the reporting period, involving a total of 435 stores[13] - The company acquired 80% of Hefei Dekang Pharmacy Chain Co., Ltd. for 25.35 million RMB, involving 31 stores, with completion expected in May 2024[13] - A total of 6.763 million RMB was spent to acquire tangible and intangible assets of 48 stores from Guangdong Hengda Pharmacy Chain Co., Ltd., with completion expected in September 2024[13] - The company plans to acquire 100% of Chongqing Shizhen Pavilion Runxiang Pharmacy Co., Ltd. for 31 million RMB, involving 10 stores, completed in January 2024[14] - The acquisition of 34 stores from Jixi Huatai Pharmacy Chain Co., Ltd. for 10.2 million RMB is expected to be completed in January 2024[14] - The company is set to acquire 65% of Shanghai Good Neighbor Pharmacy Chain Co., Ltd. for 31.8 million RMB, involving 15 stores, with completion in January 2024[14] - The company is in the process of acquiring 70% of Rugao Fengle Pharmacy Chain Co., Ltd. for 10.5 million RMB, involving 17 stores, with completion expected in September 2024[17] - The company is currently working on acquiring 80% of a new company formed by integrating stores from Handan Kangji Pharmacy Chain Co., Ltd. for 11.93 million RMB, involving 24 stores[17] Research and Development - The company's R&D expenses for the first three quarters of 2024 were CNY 47,991,222.78, up from CNY 36,040,819.29 in the same period of 2023, reflecting a growth of approximately 33.3%[22] Shareholder Information - The total number of common shareholders at the end of the reporting period is 40,989, with the top 10 shareholders holding significant stakes[10] - The largest shareholder, Ke Yunfeng, holds 242,591,847 shares, representing 21.30% of the total shares[12]